Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Average Recommendation of “Moderate Buy” by Brokerages

Chronological Source Flow
Back

AI Fusion Summary

Vanda, Amylyx, Terns, Ferguson, and Verizon all receive moderate‑buy consensus ratings, with varying buy/hold/sell splits and 12‑month targets of $14.90, $20.11, $56.30, $267.27, and $50.56 respectively. Flagship Capital bought 51,974 Verizon shares (~$2.12M).
10/04 09:18 defenseworld.net
6 Πηγές
10/04 09:54 defenseworld.net
10/04 10:34 defenseworld.net
10/04 10:34 defenseworld.net
10/04 11:22 defenseworld.net
10/04 12:08 defenseworld.net
Comments
Loading...
0